Neutrophils are traditionally viewed as the "infantry" of the innate immune system—short-lived cells that arrive first at the site of infection to swallow pathogens. However, research across dozens of inflammatory and vascular conditions reveals a more complex and potentially destructive behavior: the release of Neutrophil Extracellular Traps (NETs).
These "DNA webs" are not merely passive debris. They act as active biological scaffolds that bridge the gap between inflammation and blood clotting, a process known as immunothrombosis. While intended to ensnare bacteria, the dysregulated release of NETs drives the pathology of diseases ranging from ischemic stroke and sepsis to chronic skin conditions and organ fibrosis.
The Mechanism of NETosis
The process of releasing these traps, termed NETosis, occurs through two primary pathways. In "suicidal" NETosis, as described by Hang Yang and Martin Herrmann in New Insights into Neutrophil Extracellular Traps: Mechanisms of Formation and Role in Inflammation, the neutrophil undergoes a programmed death triggered by reactive oxygen species (ROS). The nuclear envelope breaks down, mixing DNA with antimicrobial proteins, and the cell membrane eventually ruptures to deploy the web.
Alternatively, neutrophils can engage in "vital" NETosis. In this mode, cells release nuclear material via vesicular transport, allowing the remaining "cytoplasts" to stay alive and continue moving or phagocytosing pathogens. This rapid deployment mechanism, highlighted by Mengting Yao and Jianwen Mo in Neutrophil extracellular traps mediate deep vein thrombosis: from mechanism to therapy, ensures that the immune system doesn't lose its first responders while still deploying extracellular defenses.
The Scaffold of Immunothrombosis
The most critical insight into why NETs are so dangerous lies in their physical structure. The extracellular DNA provides a sticky, negatively charged framework that captures not just bacteria, but also platelets and red blood cells.
This interaction transforms a localized immune response into a systemic clotting event. As WenBo Yan notes in Neutrophil Extracellular Traps in Sepsis and Sepsis-Related Organ Dysfunction, these scaffolds recruit platelets and coagulation factors, facilitating the formation of micro-clots that obstruct blood flow to vital organs.
In the context of stroke, this scaffolding has practical clinical consequences. Jiaqi Jin and Xin Gao have shown that NETs are often decorated with Tissue Factor, which initiates a pro-coagulant feedback loop. This makes blood clots significantly more stable and resistant to standard "clot-busting" treatments. Indeed, Takaya Kitano found that older thrombi, which have a higher density of NETs, are much harder to remove during mechanical thrombectomy procedures (An Older Thrombus Delays Reperfusion after Mechanical Thrombectomy for Ischemic Stroke).
Collateral Damage and Chronic Inflammation
Beyond clotting, NETs act as a source of "friendly fire" that prevents tissue healing. In diabetic foot ulcers, a hyperglycemic environment triggers an "imbalance" where neutrophils flood the wound and release excessive NETs. Xiajun Liang and Chenghe Qin demonstrate that these traps fuel chronic inflammation, preventing the wound from transitioning to the proliferative healing phase (Neutrophil Extracellular Trap-Related Genes and Immune Infiltration in Diabetic Foot Ulcers).
This mechanism of collateral damage extends to:
- Lung Fibrosis: NETs triggered by viral insults can induce epithelial cells to undergo a "mesenchymal transition," essentially reprogramming healthy lung tissue into scar tissue (Caopei Zheng, Alveolar epithelial cell dysfunction and epithelial-mesenchymal transition in pulmonary fibrosis pathogenesis).
- Autoimmunity: In Systemic Lupus Erythematosus (SLE), Type I interferon signaling drives the overproduction of NETs, which damage the vascular lining and impair the body's ability to manage cholesterol (Wendy I. White, Alteration of mediators of vascular inflammation by anifrolumab).
- Metabolic Stress: Saturated fatty acids can act as molecular triggers for NETosis. Juan Tao found that in obesity-related psoriasis, these fatty acids bind to receptors on neutrophils, initiating a cycle of inflammation that makes the disease resistant to standard biologic therapies (Saturated fatty acids-induced neutrophil extracellular traps contribute to exacerbation and biologic therapy resistance in obesity-related psoriasis).
Reprogramming the First Responders
Because NETs are so central to these diverse pathologies, researchers are looking for ways to "calm" hyperactive neutrophils or break down the traps once they form.
One approach is enzymatic: using DNase I to digest the DNA scaffold of the traps. Another is metabolic: Xueting Chen and Shengcai Qi discovered that D-mannose can inhibit the inflammatory glycolysis that fuels neutrophil over-activation (D-mannose alleviates chronic periodontitis in rats by regulating the functions of neutrophils).
Perhaps most surprisingly, lifestyle interventions may "reprogram" these cells. Tae Yeon Kim and Kihoon Yuk demonstrated that exercise preconditioning in mice leads to the development of neutrophils that are less prone to migrating into brain tissue and less likely to release damaging NETs following a stroke (Exercise preconditioning alleviates photothrombotic ischemic stroke in mice by orchestrating neutrophils).
By viewing the neutrophil not just as a defender but as a potential architect of tissue destruction, this research direction offers a unified framework for understanding how the body's most basic immune response can become its own worst enemy.